Related Experiment Videos
Plasma aldosterone and renin activity
1Institute of Child Health, University of Liverpool.
Insights
This study shows that aldosterone and renin activity are parallel in infants with congestive heart failure, indicating a hyperactive renin-angiotensin-aldosterone system. Captopril treatment effectively blocks this system.
Area of Science:
- Pediatric Cardiology
- Endocrinology
- Pharmacology
Background:
- Congestive heart failure (CHF) in infants involves the renin-angiotensin-aldosterone system (RAAS).
- Understanding RAAS activity is crucial for managing pediatric CHF.
Purpose of the Study:
- To investigate the relationship between plasma aldosterone and plasma renin activity in infants with CHF.
- To assess the impact of captopril on RAAS activity in these patients.
Main Methods:
- Paired measurements of plasma aldosterone and plasma renin activity were performed in eight infants with CHF.
- Six patients underwent repeat measurements after initiating captopril therapy.
Main Results:
- A parallelism between plasma aldosterone and plasma renin activity was observed, suggesting a hyperactive RAAS.
- Captopril administration resulted in biochemical blockade of the RAAS.
Conclusions:
- Infants with CHF exhibit a hyperactive RAAS.
- Captopril is effective in blocking the RAAS in pediatric patients with CHF.
Abstract:
Eight infants had paired measurements of plasma aldosterone and plasma renin activity while being treated for congestive heart failure. There is parallelism with aldosterone and renin activity in the presence of a hyperactive renin-angiotensin-aldosterone system. Six patients had plasma renin activity and plasma aldosterone measured after commencing captopril and we have shown biochemical blockade of the renin-angiotensin-aldosterone system.